District court’s order dismissing the action with prejudice held to be nonfinal due to counterclaims In a decision Thursday, the Federal Circuit affirmed a district court's denial of a preliminary injunction, and held it did not have jurisdiction over the remainder of the appeal because there was no final judgment. It was undisputed there was no infringement under the district court's claim construction of the single element at issue. After […] Continue Reading →
Federal Circuit invalidates Patent on Nobel-Prize winning invention after 50 years of prosecution In an appeal from the Board of Patent Appeals and Interferences, the Federal Circuit affirmed the Board's rejection of the claims based upon obviousness-type double patenting over previously-granted related patents. The technical aspects of the invention are complex, but are overshadowed by the procedural aspects of this reexamination. The majority and dissenting opinions seem to […] Continue Reading →
Substantial question regarding validity insufficient to defeat likelihood of success? In a recent decision, the Federal Circuit affirmed a district court's grant of a preliminary injunction concerning the manufacture of an extended release formulation of an antibiotic. In a lengthy opinion, the Federal Circuit applied the Supreme Court's obvious-to-try logic from KSR to pharmaceutical patents. Notably, the court used the unpredictability of the pharmaceutical arts […] Continue Reading →
Federal Circuit clarifies burdens of proof when priority to earlier application is contested In a recent decision, the Federal Circuit affirmed a district court's determination that the asserted claims of a patent were not entitled to the effective filing date of the earliest application in a chain of four applications, and that as a result the claims were anticipated by intervening prior art. The court explained its recent […] Continue Reading →
Disclosure of single antibody insufficient to describe genus of related antibodies In a recent decision, the Federal Circuit affirmed the decision of the Board of Patent Appeals and Interferences sustaining in part the examiner's final rejection of the broadest claim in an application, directed to methods of treating neurofibrosarcoma using monoclonal antibodies. The Board reversed the examiner's rejection of the claim for lack of enablement, but […] Continue Reading →
Federal Circuit declines to consider constitutionality of BPAI judge appointments, affirms rejection In a decision this week, the Federal Circuit decided a case involving both obviousness and the Appointments Clause relating to allegedly unconstitutional appointment of members of the Board of Patent Appeals and Interferences. The court determined that appellants failed to timely raise the issue of the constitutionality of the Appointments Clause by not presenting it […] Continue Reading →
Bilski: No machine or transformation, no patentable method, at least for now As we reported Thursday, the Federal Circuit has decided In re Bilski, an en banc decision regarding the scope of patentable subject matter. Specifically, the court addressed what is necessary for a method to fall within the scope of patentable subject matter under § 101. The court, after examining the relevant Supreme Court cases on […] Continue Reading →
Federal Circuit reaffirms anticipatory reference must have all elements as arranged in the claim In a recent decision, the Federal Circuit affirmed a district court's finding of indefiniteness but reversed the district court's holding of anticipation of other claims. The district court held the means-plus-function limitations did not have corresponding structure disclosed in the specification, rendering them indefinite, and that the combination of two examples in a prior art […] Continue Reading →
Bilski decided The decision is available here. It adopts the "machine-or-transformation" test for patentable subject matter. As stated by the majority: The machine-or-transformation test is a two-branched inquiry; an applicant may show that a process claim satisfies § 101 either by showing that his claim is tied to a particular machine, or by showing that his claim […] Continue Reading →
If no anticompetitive effect outside exclusionary zone of patent, reverse payment OK in ANDA cases In a recent decision, the Federal Circuit upheld the district court's grant of summary judgment in an antitrust case. At issue was whether reverse payments (from the patentee to the accused infringer) in the context of the Hatch-Waxman Act violated antitrust laws. The Federal Circuit observed that "[t]he essence of the inquiry is whether the […] Continue Reading →